ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...
This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...
The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, /PRNewswire/ -- Portrai, Inc. today announced ...
Vietnam Investment Review on MSN
Portrai presents 11 AI spatial transcriptomics posters at AACR
SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial transcriptomics capabilities at the ...
PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...
As the “Method of the Year 2024”, spatial proteomics (SP) enables in situ characterization of protein localization, abundance ...
Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
Genomic analysis reveals squid and cuttlefish evolved in deep oceans, survived mass extinction in refuges, and later rapidly diversified, following a “long fuse” evolutionary pattern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results